SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-686451
Filing Date
2016-08-19
Accepted
2016-08-19 16:13:04
Documents
7
Period of Report
2016-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d187158d8k.htm 8-K 25299
2 EX-1.1 d187158dex11.htm EX-1.1 118335
3 EX-4.3 d187158dex43.htm EX-4.3 161130
4 EX-5.1 d187158dex51.htm EX-5.1 17646
5 EX-12.1 d187158dex121.htm EX-12.1 24812
6 GRAPHIC g187158g0819065716917.jpg GRAPHIC 1842
7 GRAPHIC g187158g75j81.jpg GRAPHIC 6524
  Complete submission text file 0001193125-16-686451.txt   360172
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 161843309
SIC: 2836 Biological Products, (No Diagnostic Substances)